2. Academic Validation
  3. Embryonic stem cell-derived small extracellular vesicles alleviate lead-induced cochlear spiral ganglion neurons injury by activating PI3 K/AKT signaling pathway

Embryonic stem cell-derived small extracellular vesicles alleviate lead-induced cochlear spiral ganglion neurons injury by activating PI3 K/AKT signaling pathway

  • Sci Prog. 2025 Jul-Sep;108(3):368504251358007. doi: 10.1177/00368504251358007.
Lu Wang 1 2 3 4,  Yijiang Bai 1 2 3 4,  Yuanyuan Sun 5 6,  Li Li 7,  Ye He 1 2 3 4,  GuoWei Li 1 2 3 4,  Di Liu 5 6,  Zhijun Huang 5 6,  Jian Song 1 2 3 4,  Hong Wu 1 2 3 4,  Hui Li 5 6,  Xuewen Wu 1 2 3 4
Affiliations

Affiliations

  • 1 Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • 2 Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, Hunan, China.
  • 3 Clinical Research Center for Pharyngolaryngeal Diseases and Voice Disorders in Hunan Province, Changsha, Hunan, China.
  • 4 National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, China.
  • 5 Department of Reproductive Medicine, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
  • 6 Clinical Research Center for Women's Reproductive Health in Hunan Province, Changsha, Hunan Province, China.
  • 7 Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
PMID: 40630004 DOI: 10.1177/00368504251358007
Abstract

ObjectiveEmbryonic stem cell (ESC)-derived small extracellular vesicles (sEVs) exhibit considerable potential as an innovative therapeutic approach in the fields of regenerative medicine and disease management. This in vitro study aimed to evaluate the protective efficacy of ESC-sEVs against lead acetate (PbAc)-induced damage in cochlear spiral ganglion neurons (SGNs).MethodsCochlear SGNs of neonatal rats were primarily cultured and administrated with (i) serum-free medium (control); (ii) 25 μM PbAc; (iii) 0.05 μg/μl ESC-sEVs (ESC-sEVs); (iv) 25 μM PbAc + 0.05 μg/μl ESC-sEVs (PbAc + ESC-sEVs). After treatment, cell viability of SGNs was assessed by CCK-8 assay. The changes in levels of Reactive Oxygen Species, lipid peroxides, and Apoptosis were detected by immunofluorescence and flow cytometry. The protective mechanisms of ESC-sEVs against lead-induced SGNs damage were elucidated by RNA Sequencing and western blot analysis.ResultsThe findings revealed that ESC-sEVs significantly increased the viability of SGNs subjected to PbAc exposure. Immunofluorescence and flow cytometry revealed that ESC-sEVs effectively attenuated oxidative stress, lipid peroxidation, and apoptotic processes in PbAc-exposed SGNs. Furthermore, RNA Sequencing and western blot analysis demonstrated that ESC-sEVs activated the PI3 K/Akt signaling pathway, which plays a pivotal role in alleviating lead-induced neuronal injury.ConclusionIn conclusion, this study provides the first evidence supporting the therapeutic potential of ESC-sEVs in addressing lead-induced ototoxicity.

Keywords

Lead acetate; PI3 K/AKT signaling pathway; embryonic stem cell; small extracellular vesicles; spiral ganglion neurons.

Figures
Products
Inhibitors & Agonists
Other Products